Vaccinex, Inc. (VCNX)
USD 1.0
(66.67%)
USD 1.0
(66.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -22.88 Million USD | -14.97% |
| 2022 | -19.9 Million USD | 11.49% |
| 2021 | -22.49 Million USD | 20.62% |
| 2020 | -28.33 Million USD | 11.51% |
| 2019 | -32.01 Million USD | -17.35% |
| 2018 | -27.28 Million USD | -29.27% |
| 2017 | -21.1 Million USD | -4.17% |
| 2016 | -20.25 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.07 Million USD | -1.72% |
| 2024 Q2 | -5.72 Million USD | -12.77% |
| 2023 FY | -22.88 Million USD | -14.97% |
| 2023 Q1 | -4.98 Million USD | 2.6% |
| 2023 Q4 | -4.98 Million USD | 14.5% |
| 2023 Q2 | -7.07 Million USD | -41.94% |
| 2023 Q3 | -5.83 Million USD | 17.56% |
| 2022 Q3 | -4.79 Million USD | 11.28% |
| 2022 FY | -19.9 Million USD | 11.49% |
| 2022 Q1 | -4.59 Million USD | 16.75% |
| 2022 Q2 | -5.4 Million USD | -17.57% |
| 2022 Q4 | -5.11 Million USD | -6.82% |
| 2021 Q2 | -5.66 Million USD | 9.15% |
| 2021 Q1 | -6.24 Million USD | -2.48% |
| 2021 FY | -22.49 Million USD | 20.62% |
| 2021 Q4 | -5.51 Million USD | -8.99% |
| 2021 Q3 | -5.06 Million USD | 10.69% |
| 2020 Q2 | -6.5 Million USD | 9.21% |
| 2020 Q1 | -7.15 Million USD | -12.94% |
| 2020 Q4 | -6.08 Million USD | 29.06% |
| 2020 FY | -28.33 Million USD | 11.51% |
| 2020 Q3 | -8.58 Million USD | -32.05% |
| 2019 Q2 | -8.85 Million USD | 3.09% |
| 2019 FY | -32.01 Million USD | -17.35% |
| 2019 Q4 | -6.33 Million USD | 17.44% |
| 2019 Q3 | -7.67 Million USD | 13.32% |
| 2019 Q1 | -9.14 Million USD | -6.76% |
| 2018 Q4 | -8.56 Million USD | -32.65% |
| 2018 FY | -27.28 Million USD | -29.27% |
| 2018 Q3 | -6.45 Million USD | 1.57% |
| 2018 Q2 | -6.55 Million USD | -14.85% |
| 2018 Q1 | -5.7 Million USD | 7.87% |
| 2017 Q1 | -4.9 Million USD | 0.0% |
| 2017 Q2 | -4.66 Million USD | 4.95% |
| 2017 Q3 | -5.33 Million USD | -14.27% |
| 2017 Q4 | -6.19 Million USD | -16.22% |
| 2017 FY | -21.1 Million USD | -4.17% |
| 2016 FY | -20.25 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| America Great Health | -492.64 Thousand USD | -4545.342% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -140.439% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | 23.699% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 65.916% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -44.449% |
| Better Therapeutics, Inc. | -38.26 Million USD | 40.189% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 45.608% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -91.186% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | 32.381% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | 33.511% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 78.901% |
| Evolutionary Genomics, Inc. | -2.01 Million USD | -1036.126% |
| Finch Therapeutics Group, Inc. | -34 Million USD | 32.695% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 51.258% |
| Innovation1 Biotech Inc. | -1.36 Million USD | -1573.631% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -14.773% |
| Molecular Templates, Inc. | -10.46 Million USD | -118.66% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | -62.872% |
| NexImmune, Inc. | -29.19 Million USD | 21.607% |
| Orgenesis Inc. | -53.63 Million USD | 57.333% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 55.385% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -29233.35% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -41.744% |
| Scopus BioPharma Inc. | -11.71 Million USD | -95.35% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 95.462% |
| Statera Biopharma, Inc. | -98.34 Million USD | 76.73% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -231.763% |
| Trevena, Inc. | -35.28 Million USD | 35.148% |
| Vaxxinity, Inc. | -58.28 Million USD | 60.736% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -2085.815% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 54.856% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -215.09% |